Immuno-Gene Therapeutics In Hematological Cancers: How Science Drives Study Strategy

This webinar reviews the current state of technology in gene therapeutics and examines trends in immuno-oncology and gene therapy for hematological malignancies. Topics include:

• Ingredients for successful study planning and delivery
• Operationalizing studies to achieve conclusive data outcomes
• Data-driven approach to choosing the right sites in the right countries
• Key drivers to retaining patients and meeting study endpoints
• Exploring future trajectories in outsourcing models for innovative biotech companies

Speakers: Luke Gill, Executive Director, Oncology, Strategic Development, Premier Research and Colin Hayward, Chief Medical Officer, Premier Research